LOMBARDI, GEMMA
 Distribuzione geografica
Continente #
AS - Asia 5.396
NA - Nord America 5.256
EU - Europa 2.975
SA - Sud America 452
AF - Africa 54
OC - Oceania 36
Totale 14.169
Nazione #
US - Stati Uniti d'America 5.204
HK - Hong Kong 2.613
RU - Federazione Russa 1.501
SG - Singapore 1.044
CN - Cina 908
BR - Brasile 369
IT - Italia 357
KR - Corea 342
IE - Irlanda 282
PL - Polonia 180
SE - Svezia 168
DE - Germania 138
VN - Vietnam 126
IN - India 112
FI - Finlandia 110
GB - Regno Unito 65
ID - Indonesia 60
JO - Giordania 54
FR - Francia 45
AR - Argentina 36
AU - Australia 35
NL - Olanda 29
BD - Bangladesh 28
CA - Canada 25
AT - Austria 24
IQ - Iraq 23
JP - Giappone 19
ES - Italia 18
MX - Messico 18
CH - Svizzera 16
EC - Ecuador 14
ZA - Sudafrica 14
CO - Colombia 11
BJ - Benin 10
TR - Turchia 10
UA - Ucraina 10
CI - Costa d'Avorio 8
MA - Marocco 8
BG - Bulgaria 7
UZ - Uzbekistan 7
KZ - Kazakistan 6
PK - Pakistan 6
TW - Taiwan 6
VE - Venezuela 6
BE - Belgio 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
SA - Arabia Saudita 5
CL - Cile 4
CZ - Repubblica Ceca 4
PY - Paraguay 4
AZ - Azerbaigian 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
LT - Lituania 2
MK - Macedonia 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
TN - Tunisia 1
Totale 14.169
Città #
Hong Kong 2.544
Santa Clara 1.222
Ashburn 802
Singapore 790
Seoul 342
Fairfield 338
Hefei 333
Dallas 307
Dublin 279
Chandler 203
Warsaw 179
Woodbridge 159
Beijing 148
Seattle 143
San Jose 135
Houston 130
Cambridge 115
Wilmington 104
Altamura 97
Lawrence 95
Dearborn 86
Buffalo 85
Moscow 79
Florence 74
Los Angeles 72
Ann Arbor 64
Princeton 59
Kent 55
Munich 54
Jakarta 53
Mumbai 52
Ho Chi Minh City 48
New York 47
Boston 46
Helsinki 43
The Dalles 43
San Diego 36
São Paulo 36
Melbourne 35
Lappeenranta 34
Bremen 33
Shanghai 33
Pune 28
Turku 24
Medford 23
Clifton 20
Hanoi 19
Frankfurt am Main 18
Paris 18
West Jordan 16
Nuremberg 15
Rome 14
Bengaluru 13
Grottaferrata 13
Milan 13
Orem 13
Rio de Janeiro 13
Toronto 13
Bern 12
Chicago 12
Stockholm 12
Tokyo 12
Atlanta 11
Belo Horizonte 11
Boardman 11
Brooklyn 11
Baghdad 10
Cotonou 10
Guangzhou 10
London 10
Norwalk 10
Denver 9
Haiphong 9
Vienna 9
Abidjan 8
Dhaka 8
Dong Ket 8
Falkenstein 8
Johannesburg 8
Manchester 8
Montreal 8
Redondo Beach 8
Chennai 7
Falls Church 7
Ribeirão Preto 7
San Francisco 7
Brasília 6
Colombo 6
Curitiba 6
Lambeth 6
Salvador 6
Sofia 6
Sorocaba 6
Yubileyny 6
Ankara 5
Brussels 5
Campinas 5
Hải Dương 5
Nanjing 5
Phoenix 5
Totale 10.244
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.270
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 364
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 310
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 213
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 197
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 190
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 185
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study 183
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 182
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 180
Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI 177
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 177
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 175
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 173
Biomarkers study in atypical dementia: proof of a diagnostic work-up 173
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 172
12-month survival in nonagenarians inside the Mugello study: on the way to live a century 170
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study 166
Primary Progressive Aphasia: Natural History in an Italian Cohort 166
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 165
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 163
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 162
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 162
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 162
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 161
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 160
Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area 159
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 157
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 156
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study 153
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 151
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 151
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 150
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 150
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 150
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 148
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 146
Predictors of Mortality in 433 Nonagenarians Inside the Mugello Study: A 10 Years Follow-Up Study 145
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 143
Education modulates brain maintenance in presymptomatic frontotemporal dementia 141
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 140
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 139
Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease 139
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 134
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 133
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 130
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 130
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 127
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients 127
Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI Cohort 127
Contribution of mother tongue on cognitive reserve of an Italian bilingual literature Professor 126
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 119
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 119
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 119
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 118
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 117
Emerging roles for high-density lipoproteins in neurodegenerative disorders 112
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review 112
Differential early subcortical involvement in genetic FTD within the GENFI cohort 112
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 111
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 108
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study 107
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder 107
Design and implementation of a Stroke Rehabilitation Registry for the systematic assessment of processes and outcomes and the development of data-driven prediction models: The STRATEGY study protocol 107
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 105
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 104
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 102
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 100
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 98
Medical Information Extraction with NLPPowered QABots: a Real-World Scenario 97
Definition of Reliability and Validity of Sensor-Derived Measurements in Parkinson’s Disease Population: The Inertial Study 94
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 94
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 94
Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the "Mugello study" 93
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 93
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 91
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 88
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 86
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 85
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 83
The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer’s Disease: Suggestions from a Case Report 83
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 81
Leukocyte-derived ratios are associated with late-life any type dementia: a cross-sectional analysis of the Mugello study 80
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 75
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 75
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 72
Association between blood‑based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review 71
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 69
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment 68
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 67
null 63
Totale 14.289
Categoria #
all - tutte 40.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 0 21 34 55 71 28 29
2021/2022420 10 9 38 17 6 21 9 47 31 24 85 123
2022/20231.182 99 258 64 84 53 193 176 76 134 6 20 19
2023/2024914 34 53 85 28 43 98 33 381 22 53 64 20
2024/20254.192 126 435 269 652 1.117 480 61 256 176 158 192 270
2025/20266.107 620 2.862 892 539 752 206 236 0 0 0 0 0
Totale 14.289